BridgeMD
New treatment option for Developmental Dysplasia of Hip
Official title Using Artificial Intelligence to Screen for Hip Dysplasia
ClinicalTrials.gov ID: NCT06647225
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if an ultrasound scan using artificial intelligence can accurately screen for hip dysplasia. Researchers will compare the artificial intelligence ultrasound results to the standard ultrasound measures to see if the artificial intelligence ultrasound scan can accurately screen for hip dysplasia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 20. Healthy volunteers may be eligible.
You may be able to join if
- Enrolled in the VicHip study
- Is 4-20 weeks of age at enrolment
- Is attending The Royal Children's Hospital for the purpose of the potential diagnosis of DDH
- Has a diagnostic (standard) hip ultrasound on the day of their out-patient appointment
- Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf.
You likely can't join if
- Participants will be excluded from enrolment if:
- They are currently receiving treatment for DDH
The study team makes the final eligibility decision.
Where it's taking place
- Parkville, Victoria, Australia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 weeks to 20 weeks. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Parkville, Victoria, Australia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.